Darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals relative to intravenous rHuEPO in Japanese dialysis patients

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 3, 2007, Pages 220-226

  Akizawa, Tadao ^a,d   Koshikawa, Shozo ^b   Iwasaki, Manabu ^c   Ishida, H ^e   Itami, N ^f   Miyagata, S ^g   Yumita, S ^h   Kawaguchi, H ⁱ   Aoyagi, R ^j   Tsuchida, A ^k   Matsui, N ^l   Sato, T ^m   Kanno, Y ⁿ   Ishida, Y ^o   Oguchi, K ^p   Komatsu, Y ^q   Chida, Y ^r   Matsuzaki, K ^s   Takeda, F ^t   Takao, K ^u   Takagi, N ^t   Takeuchi, S ^p   Ogura, H ^p   Ishida, N ^v   Takahashi, J ^w   Nakayama, F ^x   Mineno, T ^y   Kawade, Y ^z   Murai, H ^aa   Seno, H ^ab   Sato, Y ^ac   Horikawa, K ^ad   Miyazaki, R ^ae   Okuno, S ^af   Yamakawa, T ^af   Hayashida, S ^ag   Takasugi, N ^ah   Fujiwara, K ^ai   Fukushima, M ^aj   Obayashi, S ^ak   Mizuguchi, T ^al   Yuasa, K ^am   Miyake, S ^an   Shiroozu, A ^ao   Higashi, H ^ap   Kumagai, H ^aq   Ikeda, K ^aq   Funakoshi, S ^ar   Shinzato, K ^as   Ikeda, T ^at   Otsuka, H ^au   Yoshi, S ^av   more..

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c SEIKEI UNIVERSITY   (Japan)

^d Kitasaito Hospital ^*  (Japan)

^e Kitasaito Hospital   (Japan)

^f Nikko Kinen Hospital   (Japan)

^g Nakadori General Hospital   (Japan)

^h Kojinkai Central Hospital   (Japan)

ⁱ IWAKI Urological Clinic   (Japan)

^j Tyuetu Kidney Clinic

^k Dialysis and Rheumatology Center   (Japan)

^l TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^m Sumiyoshi Clinic Hospital   (Japan)

ⁿ Specified Medical Corporation Jisenkai Aizawa Hospital   (Japan)

^o Ikebukuro Hospital   (Japan)

^p Medical Corporation of Showakai   (Japan)

^q ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^r Nakano Clinic   (Japan)

^s Nansou Hospital Medical Corporation

^t Medical Corporation of Showakai

^u Medical Corporation of Bouseikai   (Japan)

^v Medical Corporation of Seichikai   (Japan)

^w Eda Clinic   (Japan)

^x Daini Eda Clinic   (Sweden)

^y Nakatsugawa Kyoritsu Clinic   (Japan)

^z Kaikoukai Central Clinic   (Japan)

^aa Ama Kyoritsu Clinic

^ab Anjyo Kyoritsu Clinic

^ac Hekikai Kyoritsu Clinic

^ad Shizuoka Kyoritsu Clinic   (Japan)

^ae Fujita Memorial Hospital   (Japan)

^af Shirasagi Hospital   (Japan)

^ag Tokuyama Central Hospital   (Japan)

^ah Hakuai Hospital   (Japan)

^ai Kure Kyosai Hospital   (Japan)

^aj KURASHIKI CENTRAL HOSPITAL   (Japan)

^ak Kinashi Obayashi Hospital   (Japan)

^al Kawashima Hospital   (Japan)

^am Kochi Takasu Hospital   (Japan)

^an Shimazu Hospital   (Japan)

^ao Kokura Daiichi Hospital   (Japan)

^ap ST MARY S HOSPITAL   (United States)

^aq FUKUOKA RED CROSS HOSPITAL   (Japan)

^ar Sakuramachi Clinic   (Japan)

^as Shinzato Nephro Clinic   (Japan)

^at Ikeda Hospital   (Japan)

^au IMAMURA BUN IN HOSPITAL   (Japan)

^av Okinawa Dai ichi Hospital   (Japan)

more..

Author keywords

Darbepoetin alfa; Dialysis; Hemoglobin; Renal anemia; Safety

Indexed keywords

HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTHRALGIA; ARTICLE; BLOOD PRESSURE; BRAIN INFARCTION; CLINICAL TRIAL; CONTUSION; DIARRHEA; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RHINOPHARYNGITIS; SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HEMOGLOBINS; HUMANS; JAPAN; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 34248161025     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00474.x     Document Type: Article

References (13)

1. Macdougall IC, Gray SJ, Elston O et al. Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 1999 10 : 2392 5.
2. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 2001 16 (Suppl 3 3 13.
3. Brunkhorst R, Bommer J, Braun J et al. German Aranesp Study Group. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. Nephrol Dial Transplant 2004 19 : 1224 30.
4. Nissenson AR, Swan SK, Lindberg JS et al. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. Am J Kidney Dis 2002 40 : 110 18.
5. Jadoul M, Vanrenterghem Y, Foret M, Walker R, Gray S. Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients. Nephrol Dial Transplant 2004 19 : 898 903.
6. Vanrenterghem Y, Bárány P, Mann JFE et al. Randomized trial of darbepoetin alfa for treatment of renal anaemia at a reduced dosing frequency compared with rHuEPO in dialysis patients. Kidney Int 2002 62 : 2167 75.
7. Locatelli F, Canaud B, Giacardy F, Martin-Malo A, Baker N, Wilson J. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEPO). Nephrol Dial Transplant 2003 18 : 362 9.
8. Locatelli F, Olivares J, Walker R et al. Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. Kidney Int 2001 60 : 741 7.
9. Suranyi MG, Lindberg JS, Navarro J, Elias J, Brenner RM, Walker R. Treatment of anaemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease. Am J Nephrol 2003 23 : 106 11.
10. Ling B, Walczyk M, Agarwal A, Carroll W, Liu W, Brenner R. Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease. Clin Nephrol 2005 63 : 327 34.
11. Ronald LP, Jennifer L, Bragg-Gresham JL et al. Anemia Management and Outcomes From 12 Countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 2004 44 : 94 111.
12. Eknoyan G, Levin N. IV. NKF-K/DOQI Clinical Practice Guidelines for anemia of chronic kidney disease: update 2000. Am J Kideny Dis 2000 37 : S186 S9.
13. Gejyo F, Saito A, Akizawa T et al. Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients. Ther Apher Dial 2004 8 : 443 59.